Fixed Competitive Price Reverse Osmosis Water Treatment System - N-acetyl-n,o-bis-(trimethylsilyl)-cytosine – JIN DUN
Fixed Competitive Price Reverse Osmosis Water Treatment System - N-acetyl-n,o-bis-(trimethylsilyl)-cytosine – JIN DUN
Fixed Competitive Price Reverse Osmosis Water Treatment System - N-acetyl-n,o-bis-(trimethylsilyl)-cytosine – JIN DUN Detail:
N-acetyl-n,o-bis-(trimethylsilyl)-cytosine is used as the intermediate of Gemcitabine.
Gemcitabine is a pyrimidine nucleotide analogue, which belongs to anti metabolic anticancer drugs. It can prevent the progress of DNA synthesis in a certain period, that is, S-phase. It has the characteristics of wide anticancer spectrum, unique mechanism of action, low toxicity, no cross resistance with other chemotherapeutic drugs and no superposition of toxicity. Today, gemcitabine has been approved for use in more than 90 countries, becoming the first-line drug for the treatment of non-small cell lung cancer and the “gold standard” for the treatment of pancreatic cancer.
Product detail pictures:
Related Product Guide:
Our organization promises all customers with the first-class products and solutions and the most satisfying post-sale service. We warmly welcome our regular and new clients to join us for Fixed Competitive Price Reverse Osmosis Water Treatment System - N-acetyl-n,o-bis-(trimethylsilyl)-cytosine – JIN DUN , The product will supply to all over the world, such as: Bangalore, Nepal, UK, Our products have won an excellent reputation at each of the related nations. Because the establishment of our firm. we have insisted on our production procedure innovation together with the most recent modern day managing method, attracting a sizable quantity of talents within this industry. We regard the solution good quality as our most vital essence character.
By Vanessa from St. Petersburg - 2018.03.03 13:09
Customer service staff and sales man are very patience and they all good at English, product's arrival is also very timely, a good supplier.
By Eileen from Serbia - 2018.05.22 12:13
Write your message here and send it to us
